Indefinite Delivery Contract SPE2DX15D1903

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $999,999,999 and running through November 2026, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The award does not have any set-aside designations, indicating open competition.

The task orders under this IDC, valued from hundreds to thousands of dollars, procure specific pharmaceutical and medical products such as Dantrolene Sodium, Bupivacaine Hydrochloride, Norepinephrine Bitartrate, and various other injectable medications, creams, and solutions. These deliveries support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's Medical Supply Chain division. The place of performance for these task orders is Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office and distribution facilities are located.